Pneumococcal conjugate second or third-dose vaccines (PCVc) in Eastern Mediterranean (WHO region)
Eastern Mediterranean (WHO region): Pneumococcal conjugate second or third-dose vaccines (PCVc) was 61.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Eastern Mediterranean (WHO region), 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) in Eastern Mediterranean (WHO region) is 61.0%, measured in 2025. That is the highest value across all 18 years on record.
The figure is up 13.0% on the previous year and up 19.6% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Eastern Mediterranean (WHO region) peaked at 61.0% in 2025 and was at its lowest, 0.0%, in 2008.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Eastern Mediterranean (WHO region), year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 4.0% | — |
| 2010 | 4.0% | +0.0% |
| 2011 | 7.0% | +75.0% |
| 2012 | 11.0% | +57.1% |
| 2013 | 36.0% | +227.3% |
| 2014 | 46.0% | +27.8% |
| 2015 | 51.0% | +10.9% |
| 2016 | 50.0% | -2.0% |
| 2017 | 55.0% | +10.0% |
| 2018 | 55.0% | +0.0% |
| 2019 | 56.0% | +1.8% |
| 2020 | 54.0% | -3.6% |
| 2021 | 53.0% | -1.9% |
| 2022 | 54.0% | +1.9% |
| 2023 | 52.0% | -3.7% |
| 2024 | 54.0% | +3.8% |
| 2025 | 61.0% | +13.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 2.0% | 0.0% | 4.0% | 2 |
| 2010s | 37.1% | 4.0% | 56.0% | 10 |
| 2020s | 54.7% | 52.0% | 61.0% | 6 |
Countries ranked near Eastern Mediterranean (WHO region)
- 11 Turkmenistan 98.0% compare
- 11 El Salvador 98.0% compare
- 11 Portugal 98.0% compare
- 11 Costa Rica 98.0% compare
- 11 Saudi Arabia 98.0% compare
- 11 Mauritius 98.0% compare
More health data for Eastern Mediterranean (WHO region)
- Measles - number of reported cases 83,590 (2025)
- Total tetanus - number of reported cases 524 (2025)
- Diphtheria - number of reported cases 5,830 (2025)
- Pertussis - number of reported cases 14,992 (2025)
- Neonatal tetanus - number of reported cases 482 (2025)
- Underweight among adults, BMI < 18.5 kg/m2 (age-standardized estimate) 5.7% (2024)
- Obesity among children and adolescents, BMI-for-age > +2 standard 11.5% (2024)
- Obesity among adults, BMI ≥ 30 kg/m2 (crude estimate) 27.7% (2024)
- Overweight among children and adolescents, BMI-for-age > +1 standard 23.4% (2024)
- Neonatal mortality rate 23.78 (2024)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Eastern Mediterranean (WHO region)?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Eastern Mediterranean (WHO region) was 61.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Eastern Mediterranean (WHO region)?
- The highest recorded value was 61.0% in 2025.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Eastern Mediterranean (WHO region)?
- The lowest recorded value was 0.0% in 2008.
- How does Eastern Mediterranean (WHO region) rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Eastern Mediterranean (WHO region) ranks 9th out of 11 groups with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Eastern Mediterranean (WHO region)?
- Over the last ten years it is up 19.6%. The long-run trend across the full record is volatile.
- Where does this Eastern Mediterranean (WHO region) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).